Search results for “Human disease” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 3,330 patents, we discovered top 452 key players by total patent application. ZymoGenetics, Inc., Novartis AG, UCB Biopharma SRL are dominant in this area. They take 19.28% of the total patent filing.
Washington, United States
Patent: 348
Basel-Stadt, Switzerland
Patent: 157
Belgium
Patent: 137
Germany
Patent: 115
Spain
Patent: 99
California, United States
Patent: 56
Pennsylvania, United States
Patent: 50
France
Patent: 49
California, United States
Patent: 49
Jiangsu Sheng, China
Patent: 47
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 76 patents, we discovered top 14 start-ups by total patent application. Synthekine, Inc., Institut National de la Santé et de la Recherche Médicale, Perricone Hydrogen Water Co. LLC are active in this area.
STARTUP
California, United States
Patent: 20
STARTUP
France
Patent: 16
STARTUP
Connecticut, United States
Patent: 9
STARTUP
Shanghai ComGen Biopharmaceutical Co., Ltd.
Shanghai Shi, China
Patent: 7
STARTUP
DUBLIN, Ireland
Patent: 7
STARTUP
California, United States
Patent: 4
STARTUP
Colorado, United States
Patent: 3
STARTUP
California, United States
Patent: 2
STARTUP
AmiNIC ApS
Syddanmark, Denmark
Patent: 2
STARTUP
California, United States
Patent: 2
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 842 patents applied in the last 5 years. We discover 235 most active companies in this area. The fast-growing Pieris Pharmaceuticals GmbH, Second Genome, Inc., UCB Biopharma SRL take 16.39% of patent filing during this period.
Germany
Patent: 52
California, United States
Patent: 49
Belgium
Patent: 37
Glaxosmithkline Intellectual Property Development Ltd.
East Sussex, United Kingdom
Patent: 36
California, United States
Patent: 27
Missouri, United States
Patent: 24
The Board of Regents of The University of Texas System
Texas, United States
Patent: 22
STARTUP
California, United States
Patent: 20
New York, United States
Patent: 17
France
Patent: 16
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 842 patents in last 5 years, we discover 155 new entrants. Second Genome, Inc., Glaxosmithkline Intellectual Property Development Ltd., Fimbrion Therapeutics, Inc. are the most active new entrants in this area.
California, United States
Patent: 49
Glaxosmithkline Intellectual Property Development Ltd.
East Sussex, United Kingdom
Patent: 36
Missouri, United States
Patent: 24
STARTUP
California, United States
Patent: 20
New York, United States
Patent: 17
France
Patent: 14
Lisboa, Portugal
Patent: 12
United States
Patent: 11
Utrecht, Netherlands
Patent: 11
Genome International Corp.
Wisconsin, United States
Patent: 6
Research Institutions
Order by:
Innovation Intensity
With the analysis among 966 patents, we discovered top 139 universities and scientific research institutions by total patent application. Regents of the University of Colorado, Consejo Superior de Investigaciones Científicas, Massachusetts Institute of Technology are dominant in this area. They take 19.36% of the total patent filing.
Colorado, United States
Patent: 32
Madrid, Spain
Patent: 26
Massachusetts, United States
Patent: 23
Vlaams-Brabant, Belgium
Patent: 20
United States
Patent: 19
Vlaams-Brabant, Belgium
Patent: 17
Texas, United States
Patent: 13
United States
Patent: 12
Massachusetts, United States
Patent: 12
New York, United States
Patent: 12
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: